Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy
Related Experiment Video
Updated: May 10, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Christine Dambietz1, Michael Heming1, Tobias J Brix2
1Department of Neurology With Institute of Translational Neurology, University Hospital Münster, Albert-Schweitzer-Campus 1, Bldg A1 48149, Münster, Germany.
Abstract:
Cryptococcal meningitis (CM) is a severe fungal disease in immunocompromised patients affecting the central nervous system (CNS). Host response and immunological alterations in the cerebrospinal fluid (CSF) after invasion of Cryptococcus neoformans to the central nervous system have been investigated before but rigorous and comprehensive studies examining cellular changes in the CSF of patients with cryptococccal meningitis are still rare. We retrospectively collected CSF analysis and flow cytometry data of CSF and blood in patients with CM (n = 7) and compared them to HIV positive patients without meningitis (n = 13) and HIV negative healthy controls (n = 7). Within the group of patients with CM we compared those with HIV infection (n = 3) or other immunocompromised conditions (n = 4). Flow cytometry analysis revealed an elevation of natural killer cells and natural killer T cells in the CSF and blood of HIV negative patients with CM, pointing to innate immune activation in early stages after fungal invasion. HIV positive patients with CM exhibited stronger blood-CSF-barrier disruption. Follow-up CSF analysis over up to 150 days showed heterogeneous cellular courses in CM patients with slow normalization of CSF after induction of antifungal therapy.
Insights
Cryptococcal meningitis (CM) involves fungal invasion of the central nervous system (CNS). Studies show elevated natural killer cells in HIV-negative CM patients, indicating early immune activation and disrupted barriers in HIV-positive patients.
Area of Science:
- Immunology
- Neuroscience
- Infectious Diseases
Background:
- Cryptococcal meningitis (CM) is a severe CNS fungal infection primarily affecting immunocompromised individuals.
- Previous research on host responses in cerebrospinal fluid (CSF) is limited, with few comprehensive studies on cellular changes in CM patients.
- Understanding cellular dynamics in the CNS is crucial for managing this life-threatening condition.
Purpose of the Study:
- To investigate and compare cellular changes in the CSF and blood of patients with CM.
- To differentiate immune responses in HIV-positive versus HIV-negative CM patients and compare them to controls.
- To analyze the longitudinal changes in CSF cellularity during antifungal therapy.
Main Methods:
- Retrospective analysis of CSF and blood samples from CM patients (n=7), HIV-positive patients without meningitis (n=13), and HIV-negative healthy controls (n=7).
- Flow cytometry was used to analyze cellular populations in CSF and blood.
- Comparison of cellular data between CM patients with HIV (n=3) and other immunocompromised conditions (n=4).
Main Results:
- Elevated natural killer (NK) cells and natural killer T (NKT) cells were observed in the CSF and blood of HIV-negative CM patients, suggesting innate immune activation.
- HIV-positive CM patients demonstrated more significant disruption of the blood-CSF barrier.
- Follow-up CSF analysis up to 150 days revealed heterogeneous cellular recovery patterns in CM patients, with slow normalization post-treatment.
Conclusions:
- Innate immune activation, characterized by increased NK and NKT cells, is evident in HIV-negative CM patients.
- Blood-CSF barrier integrity is compromised in HIV-positive CM patients.
- Cellular recovery in the CSF of CM patients is variable and often slow, even after initiating antifungal therapy.
Related Concept Videos
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Fungal Phylum Microsporidia
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction

